Private equity firms Astorg, Charterhouse, and Grant Avenue are targeting the dietary supplements sector, betting on rising consumer demand for preventative health. Meanwhile, Vistria is making its debut multi-asset CV transaction, and EQT is entering the secondaries market with its acquisition of Coller Capital.

The moves reflect broader trends in private equity. The supplements space has gained traction from better data access and a cultural shift toward wellness. The secondaries market, meanwhile, offers established funds a way to acquire portfolio stakes, providing liquidity and new investment avenues for large LPs.

Today marks the final deadline for submissions to PE Hub’s Deal of the Year Awards. The awards recognize standout transactions across the private markets, making this a key moment for firms to highlight their most impactful work. Investors will be watching which deals earn recognition.